All In MedTech

Device Trial Radar · NCT06324201

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO™ System Use in Conjunction With VISITAG SURPOINT™Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation

Last checked: Nov 20, 2026Latest source record: Oct 31, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Feb 27, 2024

Primary completion

Mar 2026

Study completion Mar 2028

Sponsor

Lead sponsor
Heart Rhythm Clinical and Research Solutions, LLCAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Biosense Webster, Inc.
First posted
Mar 21, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Observational, multi-center, non-randomized, post-market study. This is a nested sub-study of the REAL AF Registry. Consecutive symptomatic drug refractory paroxysmal atrial fibrillation (PAF) patients from the registry will be screened for enrollment, prospectively or retrospectively, to this sub-study per inclusion and exclusion criteria.

Conditions

  • Paroxysmal Atrial Fibrillation

Interventions

  • Ablation ProcedureDevice

    Ablation Procedure for paroxysmal atrial fibrillation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of the QDOT Micro System use in conjunction with VISITAG SURPOINT ModuleTime frame: Day 0-7 post ablation
  2. Effectiveness of the QDOT Micro System use in conjunction with VISITAG SURPOINT Module at 12-months.Time frame: 12 months
  3. Effectiveness of the QDOT Micro System use in conjunction with VISITAG SURPOINT Module at 24-months.Time frame: 24 months

1 more outcomes with a free account

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • Arrhythmia Institute at Grandview

    Birmingham, Alabama · Recruiting

  • Mobile Cardiology Associates

    Mobile, Alabama · Recruiting

  • Community Memorial Health System

    Ventura, California · Recruiting

18 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.